Skip to main content

STERIS Value Stock - Dividend - Research Selection

Steris

ISIN: IE00BFY8C754 , WKN: A2PGLV

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The company was founded in 1985 and is based in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Solventum, CONMED, and STERIS Shares Are Falling, What You Need To Know

2025-09-25
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs.

At US$246, Is It Time To Put STERIS plc (NYSE:STE) On Your Watch List?

2025-09-25
Today we're going to take a look at the well-established STERIS plc ( NYSE:STE ). The company's stock saw a...

Should You Hold STERIS Stock in Your Portfolio Right Now?

2025-09-23
STE posts solid Healthcare and AST growth with strong liquidity but faces macroeconomic and currency headwinds.

Dividend Champion, Contender, And Challenger Highlights: Week Of September 21

2025-09-19
This is our weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the latest in the article series here.

How Is STERIS’ Stock Performance Compared to Other Medical Devices Stocks?

2025-09-17
STERIS has outpaced its industry peers over the past year, and analysts are reasonably bullish on its future prospects.

SOLV Strong Q2 Results Signal Momentum: Is the Stock Worth Buying Now?

2025-09-16
Solventum beats on Q2 earnings, raises guidance, and powers ahead with transformation despite looming tariff headwinds.

European Infection Control Market Forecast Report 2025-2030: Outsourcing Trends Among Pharma & Medical Device Firms Boost Europe's Infection Control Market Growth

2025-09-16
Key market growth drivers include the rise in surgeries, advancements in sterilization technology, and increased outsourcing among healthcare providers. Germany is expected to lead the market due to robust health spending and technological adoption. Cleaning and disinfection products are projected to hold the largest market share, while hospitals and clinics remain the primary end-users. Major industry players include STERIS plc, Getinge AB, and Ecolab. This report offers insights into market tr

Here's Why Steris (STE) is a Strong Growth Stock

2025-09-15
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Steris PLC stock outperforms competitors despite losses on the day

2025-09-12
Steris PLC stock outperforms competitors despite losses on the day

1 Safe-and-Steady Stock with Competitive Advantages and 2 We Avoid

2025-09-12
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.